Lichen Planopilaris

Lichen Planopilaris is an inflammatory scarring alopecia where immune cells attack hair follicles, causing permanent hair loss. For patients, this often begins subtly with itching, burning, or tenderness on the scalp, sometimes accompanied by redness around the hair shafts, particularly on the crown or top of the head. As the condition progresses, small, shiny, hairless patches appear, and the skin in these areas might look slightly inflamed or even scaled. Unlike other forms of hair loss, the follicular openings in these affected areas are typically absent, indicating irreversible damage. The inflammation, driven by the body's own immune system, specifically targets and destroys the hair follicle's stem cells, replacing them with scar tissue, which is why hair cannot regrow there.

Understanding how Lichen Planopilaris (LPP) operates is crucial for effective management. It is diagnosed primarily through a scalp biopsy, where a small tissue sample is taken and examined under a microscope. This examination reveals characteristic inflammation around the hair follicles, particularly lymphocyte infiltration, and eventual destruction of the sebaceous glands and follicular structures. Sometimes, a "pull test" might show increased shedding, but the biopsy is the definitive diagnostic tool. Blood tests may be conducted to rule out other autoimmune conditions, but they don't directly diagnose LPP. The activity of the disease is often monitored by assessing symptoms, observing the spread of hair loss, and sometimes through follow-up biopsies or trichoscopy, a magnified examination of the scalp. Active LPP indicates ongoing inflammation and further hair loss, while quiescent LPP suggests the inflammation has subsided, and no new hair loss is occurring.

This condition profoundly impacts a patient's eligibility and potential outcomes from hair transplant procedures, which is why it matters significantly to those considering restoration. A hair transplant relies on the presence of healthy, viable hair follicles at the recipient site, which is precisely what LPP destroys. Attempting a transplant into an actively inflamed or scarred area is largely futile; the transplanted grafts are likely to succumb to the same immune attack that destroyed the native hair, leading to poor growth or complete failure. The body's immune system, if still active, would recognize the new follicles as foreign invaders or continue its assault on any viable tissue.

Realistically, for a hair transplant to even be considered for LPP patients, the disease must be in a quiescent, or inactive, state for an extended period, typically at least one to two years, and ideally longer. Even then, the success rate can be lower than for androgenetic alopecia patients. The scarring makes the scalp less pliable and compromises blood supply, both critical for graft survival. Furthermore, LPP can sometimes recur even in areas previously thought to be stable, potentially affecting transplanted hair. Clinics in Turkey, experienced with a diverse international patient base, are well-versed in the complexities of LPP and its implications for transplantation, often requiring comprehensive medical histories and biopsy results.

What commonly goes wrong when LPP is not properly managed or understood in the context of hair transplantation is premature surgery. Patients, eager to restore their hair, might seek a transplant before their condition is truly stable. This often results in wasted financial investment and emotional distress as transplanted hairs fail to grow or are subsequently lost to reactivated LPP. Another issue can be misdiagnosis; LPP can sometimes be confused with other forms of hair loss, delaying appropriate medical treatment for the inflammation itself. Without effectively treating and stabilizing the underlying autoimmune process, any surgical intervention is almost certainly doomed to fail.

Given these complexities, patients considering hair restoration in Turkey or elsewhere must be diligent in their approach. Crucially, ask the clinic about their experience with LPP patients specifically and what protocols they follow to ensure disease stability. Inquire about the required waiting period after achieving quiescence and what diagnostic evidence they need, such as recent biopsy reports. Ask about the potential risks unique to LPP, including the possibility of recurrence or lower graft survival rates compared to other hair loss types. Always check that the clinic emphasizes the importance of ongoing dermatological management of your LPP, even after a potential transplant, as addressing the underlying autoimmune condition is paramount, not just treating its symptom of hair loss. Do not hesitate to seek second opinions from dermatologists specializing in hair disorders before committing to surgery.